Anticoagulation Beneficial for Idiopathic Pulmonary Arterial Hypertension
source: pixabay.com

Anticoagulation Beneficial for Idiopathic Pulmonary Arterial Hypertension

According to a story from Pulmonary Advisor, the results of a recent analysis led researchers to conclude that systemic anticoagulation therapy can be beneficial for patients with idiopathic pulmonary arterial…

Continue Reading Anticoagulation Beneficial for Idiopathic Pulmonary Arterial Hypertension
New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH
source: pixabay.com

New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH

Hereditary Angioedema Hereditary angioedema (HAE) is a rare disease which causes swelling episodes throughout the body, including the airways, gastrointestinal system, and extremities. Most commonly, HAE is caused by a…

Continue Reading New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH
ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program
source: pixabay.com

ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program

According to a story from newswiretoday.com, the biopharmaceutical group Ipsen has recently announced its decision to halt its dosing of patients in its phase 3 clinical trial and its phase…

Continue Reading ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program

“We Were Most Excited to Someday Not Take Pills and to Not Do Vest Therapies”: Her Lifetime With Cystic Fibrosis

As originally reported in Cystic Fibrosis Life Foundation, Martha has spent her 24 years of life with cystic fibrosis. She was born with the rare disease which means for a…

Continue Reading “We Were Most Excited to Someday Not Take Pills and to Not Do Vest Therapies”: Her Lifetime With Cystic Fibrosis
One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise
source: pixabay.com

One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise

Ipsen is a pharmaceutical company based out of Paris. Sadly, they have just announced that they have pressed pause on not one but two studies for fibrodysplasia ossificans progressiva (FOP). FOP…

Continue Reading One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise
ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
source: pixabay.com

ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients

According to a story from Financial Buzz, the precision oncology company Notable has recently announced that it has opened enrollment for a new observational clinical trial that will focus on…

Continue Reading ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
ICYMI: The Affordable Care Act May be Ruled Unconstitutional: Patient Groups Unite to Ask for a Prompt Decision
source: pixabay.com

ICYMI: The Affordable Care Act May be Ruled Unconstitutional: Patient Groups Unite to Ask for a Prompt Decision

As originally reported in NewsRoom, the US's political volatility over the past years has thrown many policies and legislation into debate. While switching the party in both the executive and…

Continue Reading ICYMI: The Affordable Care Act May be Ruled Unconstitutional: Patient Groups Unite to Ask for a Prompt Decision

“If You’ve Grown Up With Your Disease From Day One, You Never Know What It’s Like to be Healthy.” Patient Stories in the #IAmNumber17 Campaign

As originally reported in PR Week; pharma company Takeda has been joined a plethora of rare patients groups to create the 'I am Number 17 ' campaign which features 17…

Continue Reading “If You’ve Grown Up With Your Disease From Day One, You Never Know What It’s Like to be Healthy.” Patient Stories in the #IAmNumber17 Campaign
ICYMI: The Manufacturer of Spinal Muscular Atrophy Drug Zolgensma has Made a Lottery for Life
source: pixabay.com

ICYMI: The Manufacturer of Spinal Muscular Atrophy Drug Zolgensma has Made a Lottery for Life

As originally reported in Euronews, there is limited supply of expensive medicines for rare diseases, so it can be difficult to prioritize which patients will have their lives saved when…

Continue Reading ICYMI: The Manufacturer of Spinal Muscular Atrophy Drug Zolgensma has Made a Lottery for Life
A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
source: pixabay.com

A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

The Platform Notable's automated technology platform was created to help predict which patients would respond better to which therapies. As no patient is the same, this study is paramount. Notable…

Continue Reading A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
Let’s Talk Spoonies and Compression Socks!
Compression socks come in all different styles and patterns so even though this image is from a stock website, we have no way of knowing these guys AREN'T wearing compression socks.

Let’s Talk Spoonies and Compression Socks!

I've been hearing people buzz about compression socks/stockings for a while, but I've never invested in a pair myself. They're basically what they sound like-- socks or stockings that... compress.…

Continue Reading Let’s Talk Spoonies and Compression Socks!

Blood Thinners Improves Quality of Life With Idiopathic Pulmonary Arterial Hypertension, Worsens Those with Other Variation

A medication that works for some patients with a rare disease may not be effective for others, even with the same disease. For rare diseases, this is important because sample…

Continue Reading Blood Thinners Improves Quality of Life With Idiopathic Pulmonary Arterial Hypertension, Worsens Those with Other Variation
Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
source: pixabay.com

Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA

On April 28th, 2020, Acromegaly Community, a nonprofit organization that is dedicated to supporting acromegaly patients, will be hosting a patient focused drug development meeting (PFDD). These meetings are an…

Continue Reading Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA